These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 51671)
1. Anti-synaptic antibody in allergic encephalomyelitis. II. The synapse-blocking effects in tissue culture of demyelinating sera from experimental allergic encephalomyelitis. Lumsden CE; Howard L; Aparicio SR; Bradbury M Brain Res; 1975 Aug; 93(2):283-99. PubMed ID: 51671 [TBL] [Abstract][Full Text] [Related]
2. Anti-synaptic antibody in allergic encephalomyelitis. I. Neurophysiological studies, in guinea pigs, on the exposed cerebral cortex and peripheral nerves, following immunological challenges with myelin and synaptosomes. Lumsden CE; Howard L; Aparicio SR Brain Res; 1975 Aug; 93(2):267-82. PubMed ID: 51670 [TBL] [Abstract][Full Text] [Related]
3. Myelination inhibition factor: dissociation from induction of experimental allergic encephalomyelitis. Kies MW; Driscoll BF; Seil FJ; Alvord EC Science; 1973 Feb; 179(4074):689-90. PubMed ID: 4119452 [TBL] [Abstract][Full Text] [Related]
4. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis. Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811 [TBL] [Abstract][Full Text] [Related]
5. THE APPLICATION OF TISSUE CULTURE TO THE STUDY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS. II. SERUM FACTORS RESPONSIBLE FOR DEMYELINATION. APPEL SH; BORNSTEIN MB J Exp Med; 1964 Feb; 119(2):303-12. PubMed ID: 14164484 [TBL] [Abstract][Full Text] [Related]
6. Experimental allergic encephalomyelitis. Characterization of serum factors causing demyelination and swelling of myelin. Grundke-Iqbal I; Raine CS; Johnson AB; Brosnan CF; Bornstein MB J Neurol Sci; 1981 Apr; 50(1):63-79. PubMed ID: 7229659 [TBL] [Abstract][Full Text] [Related]
7. In vivo demyelinating activity of sera from animals with chronic experimental allergic encephalomyelitis. Antibody nature of the demyelinating factor and the role of complement. Lassmann H; Stemberger H; Kitz K; Wisniewski HM J Neurol Sci; 1983 Apr; 59(1):123-37. PubMed ID: 6854341 [TBL] [Abstract][Full Text] [Related]
8. Role of complement in demyelination in vitro by multiple sclerosis serum and other neurological disease sera. Bradbury K; Aparicio SR; Sumner DW; Bird CC J Neurol Sci; 1984 Sep; 65(3):293-305. PubMed ID: 6491691 [TBL] [Abstract][Full Text] [Related]
9. Abnormal Purkinje cell activity in vivo in experimental allergic encephalomyelitis. Saab CY; Craner MJ; Kataoka Y; Waxman SG Exp Brain Res; 2004 Sep; 158(1):1-8. PubMed ID: 15118796 [TBL] [Abstract][Full Text] [Related]
10. Myelin-binding antibodies in vitro. Immunoperoxidase studies with experimental allergic encephalomyelitis, anti-galactocerebroside and multiple sclerosis sera. Johnson AB; Bornstein MB Brain Res; 1978 Dec; 159(1):173-82. PubMed ID: 83176 [No Abstract] [Full Text] [Related]
11. FUNCTIONAL STUDIES OF CULTURED BRAIN TISSUES AS RELATED TO "DEMYELINATIVE DISORDERS". BORNSTEIN MB; CRAIN SM Science; 1965 May; 148(3674):1242-4. PubMed ID: 14280011 [TBL] [Abstract][Full Text] [Related]
12. Anti-myelin basic protein antibody in experimental allergic optic neuritis and encephalomyelitis. Robin JB; Phillips TM; Rao NA Ophthalmic Res; 1985; 17(3):174-80. PubMed ID: 2409498 [TBL] [Abstract][Full Text] [Related]
13. [Clinical and experimental study on multiple sclerosis with bushen gusui tablet]. Liu XY; Sun Y Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Jan; 21(1):10-4. PubMed ID: 12577368 [TBL] [Abstract][Full Text] [Related]
14. Evoked potentials (EPs) in experimental allergic encephalomyelitis: a study of EP modifications during the course of a controlled disease. Onofrj M; Gambi D; Bazzano S; Colamartino P; Fulgente T; Malatesta G; Ferracci F Electromyogr Clin Neurophysiol; 1992 Mar; 32(3):125-35. PubMed ID: 1555527 [TBL] [Abstract][Full Text] [Related]
15. Myelin basic protein in experimental allergic encephalomyelitis is not affected at the posttranslational level: implications for demyelinating disease. Mastronardi FG; al-Sabbagh A; Nelson PA; Rego J; Roots BI; Moscarello MA J Neurosci Res; 1996 May; 44(4):344-9. PubMed ID: 8739153 [TBL] [Abstract][Full Text] [Related]
16. Introduction and comments: myelination and demyelination. Einstein ER Adv Exp Med Biol; 1978; 100():1-16. PubMed ID: 80934 [No Abstract] [Full Text] [Related]
18. Functional and neurophysiological evidence of the efficacy of trophic pharmacotherapy using an adrenocorticotrophic hormone4-9 analog in experimental allergic encephalomyelitis, an animal model of multiple sclerosis. Duckers HJ; van Dokkum RP; Verhaagen J; Lopes da Silva FH; Gispen WH Neuroscience; 1996 Mar; 71(2):507-21. PubMed ID: 9053803 [TBL] [Abstract][Full Text] [Related]
19. Evoked potential (EP) alterations in experimental allergic encephalomyelitis (EAE): early delays and latency reductions without plaques. Gambi D; Fulgente T; Melchionda D; Onofrj M Ital J Neurol Sci; 1996 Feb; 17(1):23-33. PubMed ID: 8742985 [TBL] [Abstract][Full Text] [Related]